Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06108-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Ditte Stampe Hersby und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Rigshospitalet, Copenhagen, Denmark. ditte.stampe.hersby@regionh.dk. Hauptthemen laut MEDLINE: Mutation, Lymphoma, Large B-Cell, Diffuse, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Funding: The former Hematology department at Herlev Hospital funded the next generation sequencing analyses..
Abstract (Originalsprache)
INTRODUCTION: Large B-cell lymphoma (LBCL) exhibits striking clinical and molecular heterogeneity. New approaches have emerged to explore tumor heterogeneity and classify LBCL into biological categories. Consequently, the informational requirements from diagnostic samples to provide the necessary information have increased, but the adequacy of single-site biopsies to provide such information is largely unknown. Here we describe spatial and temporal intra-patient variations in the mutational landscape of paired biopsies. METHODS: Paired biopsies from 30 patients with LBCL were obtained from spatially distinct sites at the time of primary diagnosis before treatment and/or at a subsequent relapse. The samples were sequenced using a custom designed 59-gene next generation sequencing (NGS) lymphoma panel. RESULTS: Differences in detected mutations of pathogenic or likely pathogenic significance were frequent both when comparing paired diagnostic biopsies, 2/6 (33%), and when comparing paired biopsies at primary diagnosis and relapse, 8/16 (50%). Mutational heterogeneity tended to increase with longer time interval between biopsies. Analysis of paired diagnostic and relapse biopsies revealed that certain clones present at diagnosis disappeared, while new clones emerged at relapse. Notably, TP53 mutations were detected in six out of seven patients in an extranodal location. In two cases, TP53 mutation was only detected in the relapse biopsy. Several of the mutations identified in this study are used or under investigation as targets for cancer treatments. CONCLUSION: Multi-site biopsies revealed spatial and temporal mutational heterogeneity in patients with LBCL. Our findings indicate that mutational differences between biopsy pairs can occur at all timepoints examined. This underscores the necessity of performing repeat biopsies with each relapse to capture the full spectrum of genetic aberrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Rigshospitalet, Copenhagen, Denmark. ditte.stampe.hersby@regionh.dk.
- Department of Pathology, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Pathology, Hvidovre Hospitalet, Hvidovre, Denmark.
- Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
- Department of Hematology, Zealand Hospital, Roskilde, Denmark.
Förderung
- Funding: The former Hematology department at Herlev Hospital funded the next generation sequencing analyses.
Zitieren
APA
Hersby, D. S., Schejbel, L., Breinholt, M. F., Høgdall, E., Nørgaard, P., Nielsen, T. H., Pedersen, L. M., & Gang, A. O. (2024). Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies. Annals of Hematology. https://doi.org/10.1007/s00277-024-06108-w
Vancouver
Hersby DS, Schejbel L, Breinholt MF, Høgdall E, Nørgaard P, Nielsen TH, et al. Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies. Annals of Hematology. 2024. doi:10.1007/s00277-024-06108-w
BibTeX
@article{Hersby2024,
author = {Hersby, Ditte Stampe and Schejbel, Lone and Breinholt, Marie Fredslund and Høgdall, Estrid and Nørgaard, Peter and Nielsen, Torsten Holm and Pedersen, Lars Møller and Gang, Anne Ortved},
title = {Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06108-w}
}
EUVIMED